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 Abstract 
Kampa, N. 2006. Renal scintigraphy in dogs: Evaluation of glomerular filtration 
rate measurement by 99mTc-DTPA renogram. Doctor’s dissertation. 
ISSN: 1652-6880, ISBN: 91-576-7058-7 
 
Renal scintigraphy has been used widely to measure the individual kidney 
glomerular filtration rate (IKGFR). In dogs, the estimated GFR is calculated by a 
regression equation relating the percent of the injected dose of 
radiopharmaceutical, technetium-99m DTPA (dietylene-triaminepentaacetic acid), 
taken up by the kidneys to the known GFR by standard (plasma) clearance 
normalized to bodyweight (BW). Uptake is calculated by the integral (area under 
the curve) of time activity curve (TAC) of the renogram, which is corrected for 
attenuation of radiation in the body from kidneys to body surface of the back and 
background activity. A more physiologically correct method is to normalize GFR 
to plasma volume (GFR/PV), which requires a region of interest (ROI) of the left 
ventricle (LV). The first aim of the thesis was to determine the variations within 
the standard method and minimize them to improve the accuracy of the methods.  
Physiological variability of GFR within and among dogs on different days was 
also studied. The integral method was more stable than a slope method and 
recommended to used for calculating IKGFR/BW. The best methods for 
measuring were: semi-automatic drawing of kidney ROI with 20% threshold, a 
perirenal background ROI at one pixel wide and one pixel out from kidney ROI, a 
threshold color scale rather than continuous for measuring kidney depth to 
calculate attenuation, and a time interval between 30 – 120 seconds from the start 
of the TAC. Measurement variation was also caused by significant observer 
variability, which indicates that methods must be standardized and the same 
person should measure all compared results. Physiologic day-to-day variability of 
GFR in normal dogs was mostly found between rather than within dogs, and 
accounted for most of the variability. GFR/PV was not affected by LV ROI sizes. 
Subtracting extravascular activity from the LV ROI did not improve precision, but 
increased variability due to different LV ROI sizes and time intervals chosen for 
LV plot. Manual LV ROI, without extravascular subtraction and a time interval for 
LV input between 1 and 4 minutes are recommended. 
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51Cr-EDTA Chromium-51 ethylenediaminetetraacetic acid 
99mTc-DTPA Technetiumdietylene-99m triaminepentaacetic acid 
99mTc-MAG3 Technetiumdietylene-99m mercaptoacetyltriglycine 
BSA Body surface area 
BUN Blood urea nitrogen 
BW Body weight 
ECV Extracellular fluid volume 
ERBF Effective renal blood flow 
EV Extravascular fluid 
GFR Glomerular filtration rate 
IKGFR Individual kidney glomerular filtration rate 
LK Left kidney 
LV  Left ventricle 
MBq Megabecquerel  
NK Observer, Naruepon Kampa 
PMT Photomultiplier tubes 
PV Plasma volume 
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Introduction 
Although imaging modalities can be used to evaluate renal morphology: size, 
shape and internal architecture,  and doppler ultrasound provides a relative 
assessment of blood flow velocity (renal vascular resistance) in systole and 
diastole (Nyland et al., 2002),  functional information of the kidney such as 
glomerular filtration rate (GFR) and effective renal blood flow are routinely 
derived from scintigraphy (gamma camera based method) or from blood samples 
after injecting a marker for glomerular filtration. 
 
Renal anatomy and physiology 
In the dog, the kidneys are located in the retroperitoneal space at the level of the 
upper three lumbar vertebrae.  The kidneys lie in an oblique position, tilted 
cranioventrally. The left kidney is usually located caudal and ventral to the right 
one (Evans & Christensen, 1993). The right kidney is firmly attached to the dorsal 
body wall, adjacent to the caudate lobe of the liver and has a correspondingly 
larger retroperitoneal contact area. They are not rigidly fixed, particularly the left 
kidney and may move during respiration or may be displaced by a full stomach or 
by the dog assuming different positions. 
  
 The functional unit of the kidney is the nephron. A million or more of these tiny 
complex structures are found in each kidney. Each nephron is hollow and 
comprises a renal corpuscle and renal tubule. The renal corpuscle is composed of 
two parts, a vascular structure, the glomerulus, and a hollow cup, Bowman’s 
capsule, surrounding it. The kidney receives 20-25% of cardiac output and the 
average renal plasma flow is 15 ml/min/kg of body weight (Daniel et al., 1999; 
Guyton & Hall, 2000). About 20% of this volume is filtered through the 
glomerulus, but the percentage changes because of autoregulatory mechanisms. 
The glomerular filtration of plasma controls the volume and composition of the 
body fluids. GFR is the volume of fluid filtered from the renal glomerular 
capillaries into Bowman's capsule per unit time. 
  
GFR is considered to be the best single parameter for assessing renal function 
(Levey, 1989) because it is directly proportional to the number of functioning 
nephrons (Liedtke & Duarte, 1980; Ross, 1995). Many different kinds of diseases 
can cause swelling or scarring of the nephron or glomerulus: as a direct result of 
infection, a toxic drug, autoimmune diseases etc., damaging the glomeruli which 
reduces the filtering capacity of the kidney. Blood urea nitrogen (BUN) and serum 
creatinine concentration, which most commonly are used as the standard method 
of measuring renal function, are relatively insensitive in detecting renal 
dysfunction in that they do not accumulate significantly in the blood until there is 
severe renal insufficiency. About 70-75% of the nephrons must be nonfunctional 
before these values rise above the normal range (Finco, Coulter & Barsanti, 1981; 
Krawiec et al., 1986; Ross, 1995). Thus, the limitations of BUN and serum 
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creatinine must be recognized as they cannot determine renal reserve or subclinical 
decrease in function. 
 
Control of GFR 
The GFR is directly determined by the glomerular hydrostatic pressure and the 
glomerular capillary colloid osmotic pressure, which are mediated by the 
sympathetic nervous system, hormones, autacoid (vasoactive substances that are 
released in the kidneys and act locally, such as angiotensin, prostaglandins etc.), 
and other feedback controls that are intrinsic to the kidneys (Guyton & Hall, 
2000). The GFR is controlled by autoregulatory mechanisms (intrinsic feedback 
mechanisms). The major effect of autoregulation is to maintain a relatively 
constant GFR in the face of decreased renal blood flow or a decrease in systemic 
blood pressure, and to precisely control renal excretion of water and solutes. 
Blood pressure within the glomerulus determines GFR controlled by 
vasoconstriction of the afferent or efferent arteriole, which are controlled by 
hormones or autacoid. 
 
Glomerular filtration rate measurement 
The GFR is determined by the sum of the hydrostatic and colloid osmotic forces 
across the glomerular membrane, which gives the net filtration pressure, and the 
glomerular capillary coefficient (Guyton & Hall, 2000), but these cannot be 
directly measured; therefore determination of total GFR by laboratory methods 
relies on the concept of clearance.  
 
Clearance studies 
Clearance is defined as an the theoretical volume of fluid from which an indicator 
or tracer is completely extracted a given interval of time. It has the units of ml/min 
(or ml/min/kg or ml/min/ml when normalized to tissue mass or fluid volume). 
  
Measurement of GFR is based on measurement of tracers that are cleared from 
plasma exclusively by glomerular filtration. Renal (urinary) clearance is the 
volume of blood or plasma cleared of tracer that has passed through the kidney 
and ends up in the urine (Chew & DiBartola, 1989). For GFR, plasma clearance of 
tracers equals renal clearance if the tracer is excreted only through the kidney. A 
tracer should ideally meet the following criteria: 
 
• It is excreted only through the kidney, being freely filterable through the 
glomerular capillary membranes.  
• It must be neither secreted nor absorbed by renal tubules. 
• It must by physiologically inert and not metabolized by kidneys. 
• It must not be bound to plasma proteins or to red cells, and not sifted in the 
ultrafiltration process. 
• It must be nontoxic. 
• It must be measurable with a high degree of accuracy in body fluids. 
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Clearance can be measured under steady state or non-steady state conditions. 
The gold standard of GFR measurement is to measure the urinary clearance of 
inulin at steady state. Under such circumstance, the product of urine flow rate and 
urinary concentration is equal to the product of GFR and plasma concentration. 
This technique, however, has practical limitations for clinical cases: it is time 
consuming (24 hours); it is invasive in nature as the bladder must be catheterized 
and completely emptied to collect all urine. It is rarely performed outside research 
laboratories (Finco et al., 1981; Krawiec et al., 1986; Chew & DiBartola, 1989). 
The single injection of tracer (bolus injection technique) with measurement of 
plasma clearance under non-steady conditions has been used instead. Plasma 
clearance is measured by dividing the administered dose of tracer by area under 
the plasma time-concentration curve. 
 
The iodine-containing tracer, Iohexol® which is used for radiographic contrast 
studies can be used as a filtration marker measuring GFR by plasma clearance 
method (Effersoe et al., 1990; Moe & Heiene, 1995; Brown et al., 1996; Gleadhill 
& Michell, 1996). The disadvantages are the large volume of the injection and 
samples because of required high concentration for accurate measurement in 
plasma, with risk of toxicity and blood loss in small animals. 
 
Radionuclide clearance 
 
A radiopharmaceutical is a chemical substance that contains a radioactive atom 
(radionuclide) bound to it, usually by chelation, and is suitable for in vivo use in 
the diagnosis or treatment of disease. Radionuclide clearance with a single 
intravenous injection is simple, accurate, and reproducible (Dubovsky & Russell, 
1982).The quantification of renal function by radionuclide clearance has been 
widely used because plasma concentration of a radionuclide can be measured 
accurately in a well counter at very high and very low levels. The disadvantage is 
that the measurements must be corrected for radioactive decay. 
 
The radionuclide agent of choice for an extremely accurate measurement of 
GFR is 51Cr-EDTA (chromium ethylenediaminetetraacetic acid) (Stacy & 
Thorburn, 1966). The clearance of 51Cr-EDTA is virtually identical with the 
clearance of inulin (Blaufox et al., 1996); therefore, it is a true GFR marker. 
 
At the present time, technetium-99m DTPA (dietylene-triaminepentaacetic acid) 
(99mTc-DTPA) comes closest to being the radiopharmaceutical  of choice for GFR 
determination in clinical practice because of its properties and the ease of 
preparation of for either imaging or external counting of plasma samples 
(Twardock, Krawiec & Lamb, 1991; Peters, 2004). It has been shown to give 
equivalent results to inulin clearance in dogs (McAfee et al., 1981; Krawiec et al., 
1986; Barthez et al., 1998). It is inexpensive, has low radiation, and has a short 
half life of 6 hours and most importantly, a low degree of binding to plasma 
protein, in dogs, 10% , which does not significantly influence the measured GFR 
(Twardock et al., 1991; Uribe et al., 1992). Commercially available kits use 
stannous reduction to bind 99mTc to the DTPA molecule. After intravenous 
injection of a bolus of 99mTc-DTPA, the first pass extraction of 99mTc-DTPA is 
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approximately 20%, resulting in rapid blood clearance with normal kidney 
function. The biologic half-life in man is 2.5 hours with 95% of the 99mTc-DTPA 
within the urine by 24 hours (Kim et al., 1996). 
  
The accuracy of plasma clearance estimation with a two compartment model 
depends on the number of samples used to fit the data. Using 8 blood plasma 
samples, a two compartment model of 99mTc-DTPA has a very high correlation 
(r=0.98) with the gold standard of inulin clearance (Barthez et al., 1998). For GFR 
measurement by plasma clearance of 99mTc-DTPA, collection of at least 6 samples 
has been recommended,  at 5, 15, 30, 45, 60, 90, 120 and 180 minutes (Daniel et 
al., 1999). But others (Barthez, Chew & DiBartola, 2000) showed that accurate 
GFR can be obtained by use of 4 blood plasma samples taken at specific times. 
  
The main disadvantages of the DTPA plasma clearance method is that it requires 
multiple blood sampling over 4 hours, some laboratory skill for sample analysis, 
and computer analysis. Mutiple blood sampling may be stressful for the patient 
and is time consuming (Barthez et al., 1998). 
 
Imaging methods (scintigraphic method, gamma camera based method) 
Scintigraphy is a diagnostic technique in which a two-dimensional picture of 
internal body tissue is produced through the detection of the gamma radiation 
emitted by radioactive substances injected into the body. The image is obtained 
with a gamma camera (Figure 1). 99mTc-DTPA is the radiopharmaceutical of 
choice for GFR study by scintigraphy, because DTPA meets the criteria for GFR 
measurement and energy of the emitted radiation of 99mTc is at 140 Kev, which is 
ideal for effective detection by the gamma camera. The uptake as a fraction of the 
injected activity of 99mTc-DTPA by filtration within the kidney is directly related 
to GFR (Gates, 1982; Twardock, Krawiec & Itkin, 1996). 
 
Gamma camera 
 
The gamma camera is a scintillation detector that counts the number of photons 
over a period of time, and detects their position, creating a functional image of the 
passage of the injected tracer. It detects gamma rays within a given energy 
window around the energy of the gamma photon emitted by the tracer (Figure 1). 
 
A gamma ray photon interacts with the detector by means of the photoelectric 
effect or Compton scattering with the iodide ions of the crystal.  This interaction 
causes the release of electrons which in turn interact with the crystal lattice to 
produce light, in a process known as scintillation. Only a very small amount of 
light is given off from the scintillation detector.  Light photons enter the 
photocathode which produces electrons that are proportional in numbers to the 
intensity of the light flash. Because the small number of electrons is not enough to 
generate an electrical signal, the electrons need to be amplified by photomultiplier 
tubes (PMT). The output signal from each PMT is analyzed to determine the point 
of origin (Figure 1).  The output of the gamma camera is digitized and can be 
displayed, manipulated or stored. 
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The digital image is composed of rows and columns of square individual picture 
elements called pixels. The number of rows and columns is called the image 
matrix size. The matrix size determines the number of discrete points (pixels) of 
which the image is composed. For example, an image displayed in a 64 x 64 
matrix has 64 rows and 64 columns of pixels for a total of 4,096 pixels. Each pixel 
contains data recording the number of detected counts collected during the time 
interval of the picture. In dynamic studies, a series of pictures is taken. Each 
picture is called a frame, and the intervals for each are described as the frame rate, 
or time interval per frame (e.g. 10 frames/second or 6 seconds/frame). The activity 
of each pixel in each frame is the data for the calculation of the camera-based 
method of GFR determination. A functional image of the passage of the 
radiolabelled tracer (radiopharmaceutical drug) can be obtained by taking a 
sequence of pictures of the passage of the tracer through the kidney. 
 
 
 
Figure 1.  The illustration shows the basic components of the gamma camera. The patient 
would be placed against the collimator. The collimator is next to the NaI crystal 
(scintillation detector), which is light-coupled to the photomultiplier tubes. The X and Y 
positions are determined as each absorbed gamma ray is detected. The pulse height 
analyzer discriminates the Z pulse energy level for each photon absorbed and if the energy 
value is in the predefined window centered on the photopeak of the radionuclide being 
imaged, the event is recorded along with its X and Y position and stored in a digital format 
on the computer. 
 
The gamma camera method has many advantages over the plasma clearance 
method. Firstly, renal scintigraphy is a quick, noninvasive method, requiring only 
the placement of a venous catheter and a bolus injection. The entire procedure 
takes only 15 minutes to complete. Urine or blood samples are not required.  
Secondly, serial evaluation can be used to follow the response to therapy and can 
provide prognostic information. Because of the short half-life and rapid extraction 
of 99mTc-DTPA, serial measurement can be made at intervals of a few hours, so 
the method can be used to study the effects of interventions such as therapeutic 
drug monitoring or anesthesia on renal function (Newell et al., 1997; Bostrom et 
al., 2002; Bostrom et al., 2003). Thirdly, the gamma camera based technique 
determines GFR individually for each kidney. This is very important when a 
diseased kidney is being considered for removal. 
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The 99mTc-DTPA renogram 
 
Region of interest (ROI) selection 
Once a scintigraphic image is created, actual activity (counts) can be quantified in 
any area of the image by the computer program looking up the number of counts 
within a pixel or within a designated group of pixels called a region of interest 
(ROI). A ROI is defined by drawing with the mouse or other cursor manually or 
automatically on a static image of an organ made by summing the frames of the 
dynamic study to get sufficient count density to define the limits of the organ. 
  
Time activity curve (TAC) 
The sum of the counts of each pixel within the ROI on each the frames of the 
dynamic image can be plotted against time, giving the time-activity curve (TAC) 
for the ROI. The renogram is the renal TAC recorded after tracer administration in 
a ROI delineating the kidney. A normal renogram can be described by three 
phases which partially overlap (Figure 2). 
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Figure 2. 99mTc-DTPA renogram of a normal kidney composed of three phases. 
 
1. Circulation phase (bolus phase, vascular phase or perfusion phase). A rapid 
initial rise within 15–20 seconds after the injection of radionuclide, a peak is 
followed by a down slope, which at about 20–40 seconds reaches an inflection 
point. This bolus peak is typical for the DTPA renogram as this phase reflects the 
renal blood circulation since the first pass extraction of only approximately 20% of 
the renal plasma flow passes though the glomerular membrane, and 80% remains 
in the blood. 
 
2. Uptake phase (secretary phase or functional phase). The kidney accumulates 
the radiopharmaceutical represented by a gradual increase in activity within the 
nephron through glomerular filtration. Peak renal activity in the dog was stated to 
be at 2.5–3.5 minutes after injection (Twardock et al., 1996). This phase expresses 
the functional capacity of the renal parenchyma and is therefore the most suitable 
for GFR determination by gamma camera.  
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3. Outflow phase (excretory phase). This is represented by falling slope as 
kidney activity decreases as the radiopharmaceutical passes out of the collecting 
system into the lower urinary tract. The peak of the renogram between phase 2 and 
phase 3 corresponds to the state when the amount of indicator leaving the kidney 
through the renal pelvis to the bladder exceeds the amount of tracer taken up by 
the kidney. This phase is of no practical relevance in the determination of renal 
uptake function, but is useful for evaluating obstruction to outflow, such as by 
pelvic or ureteral calculi. 
 
This renogram is the net renogram, the true counts from the kidney. The actual 
counts from the kidney ROIs also include counts from the surrounding tissues, the 
background counts, which must be subtracted. These background activities are 
measured by drawing ROIs adjacent to the kidney. In addition, the kidney activity 
has to be corrected for attenuation of radiation by the tissue of the body between 
the kidney and the body surface. 
 
Methods for calculation of GFR 
GFR can be measured by gamma camera renography with the following 
techniques: 
 
1. The integral method (Gates, 1982) (Gates’ method): the parameter determined 
is the area under the TAC of kidney after correcting for kidney background and 
attenuation. The cumulative uptake (percent dose uptake) is obtained during the 
selected time interval. The estimated GFR is calculated by a regression equation 
relating the percent dose uptake of tracer to known GFR by plasma clearance. The 
regression is based on the percent of the injected dose of radiopharmaceutical 
taken up by the kidneys, related to the known GFR by plasma clearance 
normalized to bodyweight. (Gates, 1982; Krawiec et al., 1986). In veterinary 
medicine, this is the standard method (Krawiec et al., 1986; Barthez et al., 1998; 
Daniel et al., 1999). 
 
2. The mean slope method (Shore et al., 1984) (uptake method): the parameter 
determined is the mean slope of the TAC of kidney after kidney background and 
depth correction. The estimated GFR is calculated by a regression equation 
relating the rate of uptake of tracer during the selected time interval to the known 
GFR by plasma clearance. 
 
3. The normalized slope method (Piepsz, Dobbeleir & Erbsmann, 1977): the 
TAC of each kidney is not only corrected for external background activity but also 
corrected for the tracer concentration in the blood, which creates intrarenal 
background activity, and declines during renogram.  The plasma concentration 
activity is obtained by drawing a ROI over the heart. The mean slope of the uptake 
phase of TAC of kidney after background correction is divided by the 
corresponding cardiac counts against time. 
 
4. The uptake index (Patlak-Rutland plot) method (Rehling et al., 1985; Moonen 
et al., 1994b; Peters, 1994): This method aims to correct for the vascular activity 
 16
in the kidney ROI. The method of determining GFR is the Patlak-Rutland plot. 
This plot is the mean slope of the kidney uptake curve (after background 
correction) divided by cardiac counts as a function of the integral of cardiac counts 
divided by cardiac counts, which is an equivalent of time. 
 
Factors affecting the GFR measurement by scintigraphy 
The gamma camera method has been stated as less accurate than the plasma 
clearance method of radionuclides (Russell & Dubovsky, 1989; Barthez et al., 
1998; De Santo et al., 1999; Itoh, 2003).  The gamma camera is more complex 
than the well counter used for the plasma clearance method and factors such as 
field uniformly, linearity, and spatial resolution can affect the image 
quantification. The variations and the lower accuracy in the results by the gamma 
camera method compared to the plasma clearance methods could be due to the 
above camera factors, the accuracy of the regression equation and variabilities of 
the measurements made. 
 
Quality control of scintigraphic method 
Gamma camera 
 
Routine weekly quality control of the camera is necessary to assure that imaging 
studies will be at the highest quality (Daniel, Poteet & Kowalsky, 1996). 
 
Checking of full amount of injection 
 
The radiopharmaceutical may leak at the site of injection. This needs to be 
checked to make sure that the amount of activity administered into the body is 
correct.  This can be checked by obtaining an image of the injection site. 
 
Patient motion 
 
Movement of the dog during the dynamic acquisition period may affect kidney 
counts and kidney ROIs appearance (Newell et al., 1997; Barthez et al., 1998). 
The patient may move in some cases without it being noticed. If there is 
movement, the margins of the kidney will be soft, ROIs difficult to determine, and 
the curve will show deviations of the data points below the straight line if part of 
the kidney moves out of the ROI. Slight movement can be accommodated by 
drawing kidney ROIs large enough to encompass the motion (Cosgriff, Lawson & 
Nimmon, 1992). However, this may affect the background correction. Sedation 
may be used to prevent patient movement during acquisition. In one study in dogs, 
commonly used sedative protocols had no significant effect of on measured GFR 
values (Newell et al., 1997). 
 
Dose of injected activity 
It has been shown in humans that the error induced by statistical noise is generally 
very low (<3%) when using 100 MBq 99mTc-DTPA (Moonen & Jacobsson, 1997) 
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when measuring split renal function. For adults, a relative large range of activity 
for 99mTc-DTPA between 70-200 MBq has been recommended (Prigent et al., 
1999). The dose of 99mTc-DTPA recommended for dogs ranges between 37-148 
MBq (Twardock et al., 1996; Daniel et al., 1999). 
  
Data acquisition technique 
Collimator 
 
A low-energy, general purpose collimator is recommended. High or ultra-high 
resolution collimations are not recommended for 99mTc-DTPA, as the gain in 
resolution provides no significant clinical gain, whereas loss in sensitivity require 
higher doses and higher radiation exposure (Prigent et al., 1999). 
 
Matrix and acquisition mode 
 
The matrix size should be matched to the particular study being done. A matrix 
which is too large has few counts in each pixel causing poor count statistics. A 
matrix which is too small has good count statistics of each pixel value but the 
resolution of image is less. An image matrix of 64 X 64 pixels with 16 bits of 
image depth (word mode) has been the standard for dynamic acquisition in dogs 
(Krawiec et al., 1986; Twardock et al., 1996; Barthez et al., 1998; Daniel et al., 
1999). In humans, 128 X 128 pixels is recommended as the first choice; 64 X 64 is 
the second choice (Prigent et al., 1999). Modern computers can process the larger 
amount of data with no delay. 
 
Frame rate and acquisition time 
 
Frame rates from 5 to 15 second per frame have been recommended for dogs 
(Twardock et al., 1996; Daniel et al., 1999). In humans, either 10 second or 20 
second frames are acceptable and equivalent for relative renal function 
quantitative such as GFR study (Prigent et al., 1999). Only 3 minutes of data of 
dynamic renography is required for GFR measurement in dogs (Twardock et al., 
1996; Daniel et al., 1999). Longer acquisitions have been recommended for other 
specific renographic tests such as diuresis renography (O'Reilly et al., 1996). 
 
Correction of attenuation in soft tissue  
A proportion of the gamma rays emitted from the kidney are absorbed by the 
tissue between the kidney and camera (Figure 3). The deeper the kidney, the lower 
the recorded kidney counts by the gamma camera because of the greater 
attenuation. In human, depth corrected data are significantly different from non-
depth corrected data. Correlations with creatinine clearance GFR improved 
dramatically with depth correction (Gates, 1982). In dogs, depth-correcting the 
data improved the correlations but not as much as in human (Krawiec et al., 1986) 
as the thickness of tissue between the camera and kidney in dogs is less than in 
humans. 
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The method of measurement may affect kidney depth. Kidney depth can be 
measured by ultrasound (Gruenewald, Collins & Fawdry, 1985), computed 
tomography (Taylor et al., 1993; Inoue et al., 2000) or a lateral image after the 
dynamic acquisition (Gruenewald et al., 1985; Krawiec et al., 1986; Twardock et 
al., 1996) (Steinmetz et al., 1998; Daniel et al., 1999). In humans, formulas based 
on patient characteristics such as height, weight and age have been used (Gates, 
1982) (Taylor et al., 1993). In dogs, the standard method for calculating 
attenuation is by drawing on a single lateral image the depth of each kidney from 
its center to the dorsal body surface using cursors calibrated to measured pixel size 
(Krawiec et al., 1986; Twardock et al., 1996; Daniel et al., 1999). In adult human 
studies, the lateral static image has proved to be a reliable method for depth 
measurement, with good correlation with ultrasound (Gruenewald et al., 1985). 
 
 
 
Figure 3 Cross section of abdomen of a dog at the level the center of each kidney showing 
that the kidneys are surrounded by soft tissue and abdominal organs. Some radioactivity 
from the kidney is absorbed within tissue before reaching the gamma camera. At the same 
time, the kidney ROIs also detect the activity from the organs in front of and behind the 
kidney. 
 
The kidney depth measurement causes errors in the estimated GFR (Gruenewald 
et al., 1985; Awdeh et al., 1990; Moonen & Granerus, 1992; Barthez et al., 1998; 
Delpassand et al., 2000). Variations in depth measurement for attenuation 
correction are a significant problem: a 1 cm error in the estimation of true kidney 
depth in humans leads to 14-16% difference in the calculated GFR (Gruenewald et 
al., 1985; Awdeh et al., 1990). 
 
Variation of kidney depth measurement on a lateral scintigraphic image can be 
caused by the appearance of the image.  The display of the scintigraphic images is 
one of the greatest variables among departments (Prigent et al., 1999). 
Understanding image manipulations is essential for correct processing and 
interpretation of nuclear medicine studies. In dogs, a grey scale lateral image, not 
stated if it was linear or of other type, has been used for kidney depth 
measurement (Krawiec et al., 1986; Barthez et al., 1998; Daniel et al., 1999). 
Different color scales, particularly pseudocolor displays affect the perception of 
the position of the edge of the body, thus cause different kidney depth values and 
result in variation of correction of soft tissue attenuation. Therefore the degrees of 
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variability of the effects on uptake and GFR of different color scale for measuring 
depth need to be evaluated. 
 
Kidney ROI selection and drawing 
Times for selection of frames 
 
In dynamic renal scintigraphy with 99mTc-DTPA, the physiological behavior of the 
parenchyma is not uniform as the glomeruli are located in the cortex, and with 
time, during the renogram (1-5 minutes) the concentration of activity moves from 
the cortex to the medulla as urine moves from the cortex to the tubules and 
collecting ducts and then the pelvis. Selecting frames after 3 minutes records more 
activity from the pelvis and less activity from in the cortex. Therefore to ensure 
that the entire cortex is included in the kidney ROI, and as little of the pelvis as 
possible, the frames selected for drawing the ROIs should be from the uptake 
period when activity is maximal in the cortex. 
 
In dogs, the kidney image for drawing of ROIs is stated as the summed frames 
in the 1–3 minute acquisition interval (Daniel et al., 1999).  In humans, the 
consensus is to assign the kidney ROIs using several minutes of summed images 
(Prigent et al., 1999). However, when renal function is decreased, a later summed 
image may be selected to obtain the best signal-to-noise ratio after the background 
activity has decreased (Sennewald & Taylor, 1993). 
 
Method of drawing ROI 
 
The choice of kidney ROI drawing is important for reproducibility and accuracy 
of camera-based absolute function measurement (Prigent et al., 1999). Different 
methods of kidney ROI drawing have been used in humans; manual freehand 
kidney ROI (Piepsz et al., 1977; Gates, 1982; Rehling et al., 1985; Moonen et al., 
1994b), rectangular kidney ROI (Inoue et al., 1994), semi-automatic kidney ROI 
using a threshold technique (Tomaru et al., 1998) and polar edge search (Hornof et 
al., 1988), fully automatic kidney ROI methods using spatial information for two- 
and three- dimensional images or based on artificial neural networks (Houston et 
al., 1998); factor analysis of dynamic renal study using fuzzy ROIs for the 
extraction of TAC corresponding to renal parenchyma, renal pelvis, vascular and 
spatially homogeneous background (Bergmann et al., 1999). 
 
In dogs, the standard method of kidney ROI drawing is to draw the region 
manually (Lourens, Dormehl & Goosen, 1982; Krawiec et al., 1986; Barthez et al., 
1998; Daniel et al., 1999). Manual kidney ROI drawing has been stated likely to 
be the most accurate method if done by a skilled user (Hornof, 1996). However, 
error may occur because it depends on an operator’s skill to draw the region 
accurately (White et al., 1999). In addition, subjective assessment of image 
contours can be strongly influenced by the display, particularly with pseudocolor 
displays as previously mentioned in section of attenuation correction (kidney 
depth measurement) (Hornof, 1996). This affects the perception of the edge of the 
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kidney and thus the size of the ROIs. The other methods of kidney ROI drawing 
have not been tested in dogs. 
 
Automatic kidney ROI drawing methods should minimize the error (Houston et 
al., 1998; Bergmann et al., 1999; White et al., 1999). These different ROIs 
methods perform probably equally well in humans for relative split renal function 
determination as least as long as renal function is not severely decreased (Tomaru 
et al., 1998). No single method is recommended for use in humans (Prigent et al., 
1999). 
 
Correction of background activity 
The kidney lies in the abdomen, surrounded by other organs, which contain 
differing amounts of radioactivity (Figure 3). Background activity is radioactivity 
which adds to the true activity signals from the kidney filtrate measured by the 
gamma camera. The background activity can be separated into extrarenal and 
intrarenal components. The extrarenal background activity is the scatter activity 
from the organs around the kidney such as liver, spleen and from tissues lying in 
front of and behind the kidney. The intrarenal background activity is all activity 
within the kidney that is not filtered. It originates from the renal blood pool 
activity, interstitial activity and renal pelvis activity, and decreases at a different 
rate from the extrarenal background (Moonen & Granerus, 1992). The intrarenal 
interstitial tissue background activity cannot be separated as it is already included 
in the kidney ROI itself. Within the first minutes after the injection, the 
intravascular component is rapidly falling while the interstitial part of the 
intrarenal background is slowly increasing. The relative activity of intrarenal and 
extrarenal background may change depending on kidney dysfunction. When 
kidney function is severely impaired, intrarenal blood volume is reduced and 
extrarenal background activity is high. Vascular renal neoplasms increase 
intrarenal blood volume (Moonen, 1994). 
 
Correction of extrarenal background 
 
Extrarenal background is usually corrected by finding an area outside the organ 
which is representative of the background in the organ ROI. The counts in this 
region divided by the number of pixels represents the background counts in each 
pixel of the organ ROI. This value is then subtracted from every pixel in the ROI.  
 
The extrarenal background activity level is very dependent on the position of the 
kidney in relation to other abdominal organs (Figure 3), whose size, shape and 
position may vary considerably from one individual to another. For 99mTc-DTPA, 
with its low extraction fraction and high background activity, the choice of 
location of the kidney background ROIs is important. Many regions around the 
kidneys can be chosen as background, for example: semilunar under kidney, 
rectangular around kidney, perirenal ring (Houston & Sampson, 1989; Moonen & 
Granerus, 1992; Granerus, 2000). The published studies in dogs used manually 
drawn backgrounds as small areas at the cranial and caudal poles of the kidneys 
(Krawiec et al., 1986; Twardock et al., 1996; Barthez et al., 1998; Daniel et al., 
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1999) and at only the caudal pole of the kidneys (Lora-Michiels et al., 2001). 
Small ROIs are not likely to be representative of the entire background (Figure 4). 
In humans, a two pixel wide circumferential (perirenal) kidney ROI background, 
surrounding the whole kidney and one pixel out from the kidney ROI was the best 
approximation of the extrarenal background because it incorporates the variations 
caused by the position and activity of the other abdominal organs (Moonen & 
Granerus, 1992). The most accurate size and position of perirenal ring background 
in dogs need to be evaluated. 
 
  
 
Figure 4.  Showing the different activity counts around each kidney at different positions of 
a small rectangular ROI. The average counts per pixel ranges from 83 to 235. 
 
Correction of intravascular intrarenal background 
 
Methods which correct for decline of plasma activity such as normalized slope 
Patlak-Rutland plot (uptake index) methods, use a cardiac ROI to correct for the 
intrarenal (mainly intravascular) part (Piepsz et al., 1977) (Rehling et al., 1985; 
Moonen et al., 1994b). As the cardiac ROI is a standard size, this method is 
unsuitable for application to dogs as different sized ROIs to accommodate all size 
of dogs would require a formula for each size of ROI.  
 
Time interval for measuring uptake 
Currently with the standard method for dogs, GFR estimation using percentage 
kidney uptake of 99mTc-DTPA, it is presumed that during the first 3 min after 
injection 99mTc-DTPA has not left the kidney as the percentage uptake of 99mTc-
DTPA using the integral method from 1 to 3 minute gave the best correlation with 
inulin clearance (Krawiec et al., 1986). However in one dog study, 99mTc-DTPA 
appeared in the bladder routinely within 3 min during renal scintigraphy (Barthez 
et al., 1998). In our routine clinical cases, we and Lourens et al. (1982) also 
observed that many renograms had peak activity between one and three minutes. 
After the peak, more activity is leaving the kidney than is being filtered and 
activity measured in the kidney between 1 and 3 min after the injection often 
underestimates kidney uptake, because the radiotracer may have begun to leave 
the kidney and not be available for counting. The most accurate time intervals for 
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physiological validity in dogs should be determined.  In humans, the 
recommended time interval for processing is between 60 and 150 seconds 
postinjection, unless the time to peak has been reached (Prigent et al., 1999). 
 
Physiological variability of dogs 
Reference values, not only the absolute values but also normal ranges for GFR 
varied considerably between studies (Heiene & Moe, 1998). Differences in 
technique for measuring GFR is one possible contributor to the variations in the 
reported values. The GFR may vary from dog to dog and among the dogs used to 
represent the population at different times, as the variation of GFR in dogs is 
influenced by nonrenal factors such as protein intake, hydration status, sodium 
balance, and gender. Because kidney scintigraphy is based on sampling of data in 
a short time (2 minutes) compared with plasma clearance techniques that measure 
GFR over a longer time interval (hours), GFR values may vary considerably in an 
animal with a normal renal reserve capacity. These short term physiological 
variations within a certain range for each dog are averaged in measurements made 
by clearance methods over hours. The variability of GFR between and within dogs 
has not been investigated. 
 
Normalization of GFR measurement 
GFR measured by scintigraphy was reported as ml/min/kg in dogs with the 
assumption that the renal uptake or clearance is linearly related to bodyweight 
(BW) (Krawiec et al., 1986; Barthez et al., 1998; Daniel et al., 1999). Expressing 
GFR in terms of BW may not be the most physiologically correct relationship. The 
relationship between BW and GFR becomes non-linear in very small and very 
large dogs (van den Brom & Biewenga, 1981). One study in dogs has taken into 
consideration that metabolic rate is more closely related to body surface area 
(BSA) than to BW (Moe & Heiene, 1995). In humans GFR is usually expressed to 
BSA (ml/min/m2) (Rehling et al., 1985; Inoue et al., 1998) and this also 
controversial (Peters, 1992). It was pointed out long ago that such correlations are 
physiologically invalid (Tanner, 1949), and recently, a poor relationship between 
echocardiographic measurements of heart size and BW and BSA was found 
(Cornell et al., 2004). Heart size is related to body fluid volumes and oxygen 
needs. 
 
A primary function of the kidneys is to maintain homeostasis of fluid balance 
(Guyton & Hall, 2000). The two major body fluid compartments are the 
intracellular compartment and the extracellular fluid volume (ECV).  
Approximately 2/3 of body fluid is intracellular and 1/3 is extracellular. The ECV 
is further divided into plasma volume (PV, intravascular space), and interstitial 
fluid volume that which is found in the microscopic spaces between cells 
(extravascular space, EV). Of the ECV approximately 80% is interstitial fluid and 
20% is blood plasma (PV) (Guyton & Hall, 2000). 
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Since the function of the kidneys is homeostasis of these fluid volumes, GFR 
may be normalized to volumes of body fluid compartments: ECV, PV and total 
body water (White & Strydom, 1991; Peters, 1992).  In humans, the physiological 
validity of expressing GFR in relation to ECV or PV has been demonstrated in a 
large pediatric population (Peters, Gordon & Sixt, 1994b). This normalization has 
been applied to dogs (Gleadhill, Peters & Michell, 1995). Its advantage over 
normalization to body weight or body surface area is that physiologic changes in 
GFR in response to changes in fluid volume rather than disease are automatically 
corrected for by the ratio. If GFR changes are not in proportion to the change in 
fluid volume, the GFR is abnormal (Peters, 1992; Heiene & Moe, 1998). 
 
GFR is more sensitive to PV than to ECV, because volume receptors are present 
within the blood vessel walls. PV would also be more relevant for normalizing 
GFR if the interstitial fluid were to serve as a reservoir into which fluid was 
transferred from plasma, such as a result of renal dysfunction (Peters, Allison & 
Ussov, 1994a). Normalizing GFR to PV should take into account these variations, 
and this in theory makes it a better index as it would not be affected by state of 
hydration or fluid retention caused by disease or pregnancy. 
 
A method of normalizing GFR to PV (GFR/PV) has been introduced, using the 
99mTc-DTPA gamma camera renogram and without requiring a blood sample 
(Peters et al., 1994a). A ratio of GFR/PV to GFR/ECV of 4.0, which is the ratio of 
ECV to PV, was found in humans (Peters et al., 1994a), and is the same ratio 
according to Guyton & Hall (2000). Theoretical advantages of relating GFR to 
plasma volume over the standard method of scintigraphic GFR measurement used 
in dogs are that: 
 
• It is a physiological correct. 
• It corrects for declining plasma activity. 
• It is potentially more reliable as it uses the stable Patlak plot to measure 
uptake of activity.  
• It does not require a regression equation relating uptake to GFR by plasma 
clearance.  
 
However, the validity of these principles have not been determined in practice. 
Many factors that can affect the reliability of this measurement, including the sizes 
and types of left ventricle ROI (LV ROI), and the effects of extravascular 
background activity and time interval chosen for the LV TAC used to measure 
plasma activity. 
 
Principle of GFR/PV measurement 
The principle of this measurement is based on a technique of graphical analysis of 
dynamic data, the Patlak plot (Rutland, 1979; Patlak, Blasberg & Fenstermacher, 
1983; Peters, 1994). The Patlak technique is the plotting of one mathematical term 
against another. The slope of the plot is proportional to the clearance of tracer 
from blood to a tissue compartment, in this case, the kidney. Provided no tracer 
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leaves the tissue compartment, either into a third compartment or back into 
plasma, the rate of tissue uptake of tracer is proportional to plasma concentration. 
 
The rate of 99mTc-DTPA that accumulates in the kidney following IV injection is 
equal to the product of GFR and simultaneous plasma concentration of DTPA. 
Therefore, the rate of increase of activity in the kidney, count rate (R, units of 
counts/min/min) (after background and attenuation correction) recorded from a 
ROI over the kidney at any time (t), before any filtered tracer has left the ROI, is 
equal to the product of individual kidney GFR (IKGFR, units of ml/min), and the 
plasma concentration (C, units of injected counts/min/ml). 
 
dR(t)/dt = IKGFR x C(t)      
 
At t = 0, when all tracer is theoretically confined to intravascular fluid (plasma 
volume, PV), 
 
dR(0)/dt = IKGFR x C(0)      
 
Since 
 
PV
counts/min injectedC(0) =  
 
PV
IKGFR
counts/min injected
dR(0)/dt =  
 
(0) LVαdR(0)/dt •=  
 
An indirect method is used to derive dR(0)/dt. 
 
α in units of min-1 is the slope of the Patlak plot of uptake curve/cardiac counts 
as a function of the integral of cardiac counts/cardiac counts, applied to the renal 
and left ventricular ROI. 
 
LV(t)
dtLV(t)α
LV(t)
R(t) •∫=  
 
LV (0) is derived by extrapolation of LV (t) to LV (t = 0) from a least squares fit 
to semilogarthmical LV (t). Details are in Paper IV. 
 
In this method, the actual activity in the LV ROI does not need to be known, as 
this factor is removed during the calculations since its count rate is, respectively, 
inversely and directly proportional to α and LV activity (Peters et al., 1994a). 
However in practice a large ROI may be affected by extravascular activity and a 
too small ROI by low counts and statistical noise. 
 
Extravascular activity rapidly accumulates in the thoracic wall tissues and may 
affect the slope and intercept of the semilogarithmic plot of LV activity (Bell & 
Peters, 1991). 
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Aims of the study 
The overall purpose of the thesis was to improve the GFR measurement by 
scintigraphy. The specific objectives were the following: 
 
1. To improve the accuracy of the standard method by determining sources 
of variation and minimize them. 
 
i. To compare manual and semi-automatic kidney ROIs and to 
investigate the variability within and between observers caused by 
kidney ROI drawing (Papers I and III). 
 
ii. To determine the most accurate size and position of perirenal 
kidney background ROI (Paper I). 
 
iii. To evaluate two different color scales for accuracy of measuring 
kidney depth for attenuation correction (Paper III). 
 
iv. To determine the most accurate time interval for calculations 
(Paper I). 
 
v. To compare slope method with integral method (Paper I). 
  
vi. To test the overall variability of GFR measured by scintigraphy 
using the integral method (Papers II and III). 
 
2. To determine the day-to-day variability of GFR within and between dogs 
in a group of normal dogs (Paper II). 
 
3. To adapt the method to dogs for measuring GFR/PV as an alternative to 
the standard integral method/body weight and to evaluate (Paper IV): 
 
i. The effect of different LV ROI size  
  
ii. The effect of extravascular activity background 
 
iii. The effect of different time intervals for LV ROI curve 
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Material and methods 
Experimental beagle dogs were borrowed from the Department of Small Animal 
Sciences. They were fed a standard diet and water was accessible ad lib. They 
were trained to accept procedures such as blood and urine sampling. Clinical cases 
were examined collected from 1994 to 2004. All studies were performed at the 
Department of Clinical Radiology, Swedish University of Agricultural Sciences. 
 
Dogs used 
Paper I: 10 healthy laboratory female beagles, age 2-9 years, weight 10-21 kg. 
 
Paper II: 8 healthy laboratory beagles (4 males + 4 females), age 1-6 years, weight 
10-16 kg and the dogs in paper І. 
 
Paper III: 60 clinical cases referred for evaluation of renal function during 1994-
2004. 
 
Paper IV: The dogs in paper I and paper III. 
 
Plasma clearance method (Paper I) 
The exact activity of radionuclide was measured in a well counter before injection.  
Heparinized blood samples were collected at 10, 20, 30, 60, 120, 180, and 240 
minute intervals, after the intravenous injection for the scintigraphic method using 
a separate iv cannula. A standard dose was diluted (1:1000) in a flask for 
calibration of the activity measured in a well counter to correct for counting 
efficiency and dead time losses. Activity of each sample was measured from a 
500uL aliquot of plasma in a gamma counter (Nuclear Chicago 1186 with a well-
type NaI detector, Searle Analytic Inc., Des Plaines, Iillinois, USA) for 2 minutes. 
Activity was corrected for physical decay and a decay curve was plotted using the 
program (JMP®, SAS Institute Inc. Cary, NC, USA). The decay curve was fitted to 
a double exponential function and the area under the curve measured by a 
trapezoidal model (Daniel et al., 1999). The clearance was calculated as the 
injected dose divided by the area under the curve. 
 
Scintigraphic methods (Papers I-IV) 
Acquisition of data 
A standard preparation of 99mTc-DTPA was used (TechneScan®; Mallinckrodt 
Medical B.V., Petten, The Netherlands). A low energy all purpose (LEGP) 
collimator on a gamma camera (Picker 300 SX®; Picker International Inc., 
Cleveland, OH, USA) were used.  A 64 x 64 pixel matrix was used for the 
dynamic study and 128 x 128 matrix was used for static study. The exact amount 
of radioactivity injected, approximately 70 MBq, was measured by counting the 
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activity in front of the gamma camera before and after injection, and correcting for 
radioactive decay during the time interval. The dog was positioned in left lateral 
recumbency and the gamma camera was positioned dorsally to include the kidneys 
and the thorax if possible. A dynamic acquisition was started of six frames per 
minute for five minutes. Immediately after staring acquisition, 99mTc-DTPA was 
injected intravenously as a bolus flushed by 4 ml saline solution via catheter in the 
vein. Immediately after the dynamic acquisition period, the camera was rotated 90 
degree above the dog and a static lateral 30 second image was made to measure 
the kidney depth. The camera was then returned to its original position and the 
injection tubing, cannula and syringe were counted on a stand. All data were kept 
in the computer and calculated using a program written for the nuclear medicine 
software (Hermes®; Nuclear Diagnostics, Hägersten, Sweden). If necessary the 
dynamic study was corrected for motion (Lord, Makela & Maripuu, 1999). 
 
Kidney ROI drawing 
In normal dogs (Paper I, II and IV) and in most clinical (unknown condition) dogs 
(Paper III and IV), the images from 1-2 min were summed to create a single image 
of the kidneys with sufficient counts to define the edges of the kidneys. In 
instances of poor kidney function with slow uptake and high background activity, 
the summed imaging time had to be extended to get sufficient count density to 
locate and outline the kidney. 
 
Two different methods of kidney ROIs drawing were tested, the manual and a 
semi-automatic ROI method (Papers I and III). The semi-automatic ROI method 
was called the automatic ROI method in paper I and II. This was changed to semi-
automatic ROIs in paper III and IV since this technique is not fully automatic. In 
paper I, the manual ROIs were all made by the same person to eliminate observer 
variability. ROIs were drawn semi-automatically around each kidney at threshold 
of 15, 20, 25, 30, 35 and 40% of the maximum pixel activity within the 
background subtracted kidney (Figure 5).  In papers II, III and IV, only the 
threshold of 20% of the maximum was used as this was determined in Paper I to 
be the best. 
 
 
 
Figure 5 Kidney ROI drawing using the semi-automatic technique at the different 
thresholds (in percent of maximum pixel count). 
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The variability of kidney ROI drawing 
 
The effect on the percentage uptake of 99mTc-DTPA of the individual kidney of the 
different kidney ROIs methods was tested in clinical dogs (unknown conditions) 
in paper III. The variabilities within and between observers of semi-automatic and 
manual kidney ROI drawing were investigated. Because the GFR values were 
calculated using regression equations which were slightly different between semi-
automatic and manual ROI drawing technique, the true variability was presented 
as percentage uptake of 99mTc-DTPA rather that individual kidney GFR. However, 
to express the results as GFR units for clinical use, when possible the percentage 
uptake of each kidney was converted to the estimated GFR using the regressions 
previously derived in Paper I. 
 
Background activity correction 
For correction of background activity, only the perirenal (circumferential) 
background ROI was used (Moonen & Granerus, 1992). Perirenal kidney 
background ROIs were drawn automatically one pixel wide and zero, one, and two 
pixels out from the kidney ROI (Figure 6) in paper I and at one pixel out for the 
kidney ROI in papers II, III and IV.  Background was subtracted from the kidney 
ROIs.  We did not test the small background ROI at the pole of the kidneys 
compared to perirenal background ROI in Paper I. Since this paper was published, 
we compared the effects of three kinds of background ROIs as percentage uptake 
on the 58 normal kidneys. 
 
 
 
Figure 6 Background ROIs placed 0, 1 and 2 pixels out from the kidney ROIs 
 
Kidney depth measurement and the effect of color tables on kidney depth 
for attenuation correction 
The distance from the center of each kidney to the skin (kidney depth) was 
measured on the lateral image using cursors calibrated to measured pixel size with 
a threshold (duotone) color display (Paper I, II, III and IV) and with a continuous 
red-green-blue color display (Paper III) (Figure 7). The threshold table gave a 
sharp transition at the edge of the body, set at 1% of maximum activity in the 
image.  The continuous red-green-blue color scale resembled the continuous grey 
scale color used in the original paper (Krawiec et al., 1986).  The correction for 
soft tissue attenuation was calculated using the known attenuation coefficient for 
99mTc in soft tissue (linear absorption coefficient in soft tissue = 0.153/cm). 
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Figure 7 (a) Schematic diagram of the lateral scintigraphic image of a dog for kidney depth 
measurement, the kidney depth of each kidney is measured from the dog’s back to the 
center of the kidney. (b) The threshold color table. (c) The continuous red-green-blue color 
table. 
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The effects of the two different color scales on observer variability of kidney 
depth were tested (Paper III). The within observer variations of the individual 
kidney depth and percent dose uptake of 99mTc-DTPA caused by each color table 
were calculated. For between observers variation, only kidney depth variation was 
calculated because the program did not allow calculation of percent uptake with 
saved ROIs necessary for standardization of all other factors. 
 
Time interval selection of renogram 
Different time intervals of TAC were tested in paper I. Cursors were used to 
define portions of the curve. The following time periods were tested: 30–120, 60–
120, 60–180, 30–peak (unit as second) and only the straight line part of the uptake 
curve after 30 seconds. 
 
Methods of calculation  
For the integral method, from each time period, the total counts accumulated after 
background correction were measured as area under the curve and normalized to 
counts/min. For the mean slope method, the slope of the curve was measured as 
counts per sec/sec/100MBq injected, after background correction. All methods 
(Paper I) of measuring kidney ROIs, background ROIs, and uptake (integral and 
slope method) were evaluated by a regression equation with global GFR by the 
plasma clearance method. All calculations were made in a program written for the 
Hermes® nuclear medicine software. 
 
In Papers II and III, the best correlation obtained from Paper I was incorporated 
into the program and the GFRs were measured using it and the corresponding best 
thresholds for kidney ROIs and the background ROIs. In addition, the difference 
between calculated GFR by renography and GFR measured by plasma clearance 
in Paper I was calculated by plotting the differences between the two methods are 
plotted against the averages of the two methods (Bland & Altman, 1986; Bland & 
Altman, 1999). 
 
The overall variability 
The overall variability of the integral method caused by the effects of kidney ROI 
drawing technique and kidney depth measurement together was evaluated (Paper 
II and III). In paper II, using normal dogs, the repeatability of method of the 
observer was tested using the regression equation obtained from Paper I and the 
kidney depth value was measured from the threshold table. The global estimated 
GFR value was average of 3 measurements of each study. In Paper III, two 
observers measured all studies again approximately 3-6 months after the first 
measurement to ensure that they did not remember any previous values. Both 
manual and semi-automatic kidney ROIs drawing were used and the kidney depth 
value was measured from different color scales in both observers. 
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Day-to-day variability within and between dogs 
The variations of GFR in the individual normal dogs and on three different days at 
intervals of 5 to 26 days were studied (Paper II). The global GFR of each dog was 
measured by one person (NK) three times using the best method obtained from 
Paper I. 
 
Normalization of GFR to plasma volume (GFR/PV measurement) 
For GFR/PV measurement in Paper IV, another ROI representing plasma activity 
is required. The ROI was located over the heart (left ventricle, LV). Manual and 
three different sized automatically-drawn ROIs were evaluated. The plasma 
concentration curve was calculated with and without subtracting EV activity. The 
EV activity was measured by drawing a ROI, the same size as the LV ROI, over 
the right lung symmetrically (Figure 8). Two different time intervals for LV curve 
were evaluated: at 30 –120 seconds and 60 – 240 seconds. All compared 
measurements and ROI drawings were made by one person. GFR/PV was 
calculated by the method of Peters et al. (1994a), using a program written for the 
Hermes® nuclear medicine software. 
 
 
 
 
Figure 8 LV ROI (left over heart) and EV subtraction ROI (symmetrically opposite) over 
the right lung. 
 
Statistical analyses 
In Paper I, GFR calculated by plasma clearance was correlated and related by a 
regression equation to the percent uptake and the slope of the uptake phase for 
each of the different time intervals, for manual and various thresholds of semi-
automatic kidney ROIs, and the various background ROIs tested. Linear 
regression analysis was used to determine the correlation and the predicted 
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equations. The difference between calculated GFR by renography and GFR 
measured by plasma clearance was calculated by a Bland-Altman plot (Bland & 
Altman, 1986; Bland & Altman, 1999), and 95% limits of agreement were also 
calculated. 
 
In Paper II, the mean and standard deviation of GFR for the three different 
studies from each dog were calculated. Analysis of variance (ANOVA), using 
general linear model (GLM) was used to test the variation of GFR both in 
individual dogs and in the same dog on different days, and to test the repeatability 
of the method, the intra-observer variability. The coefficient of variation (CV) (the 
ratio of the standard deviation to the mean) of the observer variability and the 
GFR of the same dog on the different days were then calculated. The repeatability 
coefficient is 1.96 √2Sw, where Sw is the standard deviation within subject and is 
the square root of residual mean square obtained by one-way ANOVA with 
subject as a factor (Bland & Altman, 1999). The relation between weight and GFR 
was analyzed by correlation coefficient. Significance was tested at a 5% limit. 
 
In Paper III, the within and between observer variability of kidney depth by the 
two different color tables (threshold and continuous red-green-blue table), the 
effect of ROI drawing (semi-automatic & manual), and the repeatability of the 
method were analyzed by Bland-Altman plots of the mean and mean difference.  
The 95% limits of agreement, 95% of the differences lie between đ – 1.96SD and 
đ + 1.96SD, was then calculated (Bland & Altman, 1986; Bland & Altman, 1999).  
These values define the range within which most differences between 
measurements by the two studies/observers lie. 
 
In Paper IV, one way ANOVA using GLM was used to determine if different 
sizes of LV ROI, effects of EV subtraction and different LV time intervals 
affected the GFR/PV value.  Significance was tested at a 5% limit. SD and CV 
were used to evaluate the variability of the method. Bland-Altman plots (Bland & 
Altman, 1986) were used to determine the effect of these parameters on GFR/PV 
values as the absolute difference and percentage of differences values (Bland & 
Altman, 2002; Dewitte et al., 2002). 
 
Results and discussion 
The mean GFR (± SD) of 29 measurements of 10 normal dogs in Paper I obtained 
by 99mTc-DTPA plasma clearance method with 7 collected blood samples was 3.44 
± 0.62 ml/min/kg, ranging between 2.53 and 5.34 ml/min/kg. As the plasma 
clearance method is considered to be accurate, the range is due to difference 
among and within dogs, physiologic variations discussed in Paper II. 
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Kidney ROI drawing (Paper I) 
In our studies, we did not sedate any of the dogs. Fewer than 20 percent of the 
studies showed some movement, which was corrected by a program realigning the 
frames from 30 seconds onward.  Sedation may be used to prevent patient 
movement during acquisition (Newell et al., 1997). However, not every 
department uses the same sedative protocols and sedation with some agents may 
affect GFR. 
 
With manual kidney ROI drawing using the integral method, the best correlation 
coefficient (r = 0.81) was derived from time intervals 30–120 seconds with the 
background ROI at 2 pixels out from the kidney. The best example of the slope 
uptake method was slightly better, the best correlation (r = 0.83) with 99mTc-DTPA 
plasma clearance found at the time interval of 30 seconds to peak of TAC using a 
background ROI one pixel out from the kidney ROI. 
 
With the semi-automatic kidney ROI drawing using the integral method, the best 
correlation of the percentage uptake of 99mTc-DTPA of both kidneys with the GFR 
by 99mTc-DTPA plasma clearance (r = 0.84) was found at the threshold of 20 % 
maximum pixel activity using kidney background ROIs 1 or 2 pixels out from the 
kidney ROIs and the time interval 30–120 seconds. With the slope uptake method, 
the best correlation (r = 0.85) with 99mTc-DTPA plasma clearance was found at the 
threshold of 35 % maximum pixel activity using a background ROI 2 pixels out 
from the kidney ROI with the time interval of 30 seconds to peak of TAC. 
 
The semi-automatic kidney ROIs were slightly more accurate than the manual 
ROIs in relation to the 99mTc-DTPA plasma clearance.  The use of automatic 
background ROIs is likely to have minimized the variability between semi-
automatic and manual kidney ROIs, compared with manual drawing of both. 
 
Effect of observer variability on kidney ROI (Paper III) 
The within observer (NK) variability of kidney ROI drawing (repeated 
measurement). The 99mTc-DTPA percentage uptake by semi-automatic kidney ROI 
was slightly higher than by manual kidney ROI in both kidneys. The 95% limits of 
agreement of 99mTc-DTPA percentage uptake between the first and second 
measurement by the same observer was wider with the manual kidney ROI than 
with the semi-automatic one. The GFR values could vary up to 10 % for the right 
kidney (RK) and 9 % for the left kidney (LK) using semi-automatic kidney ROI, 
and up to 14 % for the RK and 11 % for the LK for manual kidney ROI. 
 
Between observer variability of kidney ROI drawing. The range of 95% limits of 
agreement of 99mTc-DTPA percentage uptake was wider using manual kidney ROI 
than using semi-automatic one. It was greater than the within-observer variability 
for manual kidney ROI. The GFR value between observers caused by semi-
automatic ROI could vary up to 6 % for the RK and 8 % for the LK. Manual ROI 
could vary up to 15 % for the RK and 15 % for the LK. 
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The within observer variability of the different kidney ROI methods (semi-
automatic and manual ROI). The range of the 95% limits of agreement of the 
second observer was nearly twice that of the first observer. For the first observer, 
the different kidney ROI methods could cause variation in GFR up to 7 % for both 
kidneys. For the second observer, the GFR value could vary up to 12% for the RK 
and 11 % for the LK. As the difference in variation of GFR from the different 
regression equations for the semi-automatic and manual ROIs was only 1 %, using 
the semi-automatic equation caused only 1% of variation of GFR in these results. 
 
The variation was presented as how much of the individual kidney ROI 
variability affected the global GFR in term of the percentage of GFR value, which 
could be varied due to the kidney ROI method and observers.  The variability of 
each kidney may be additive or subtractive in their effects on global GFR because 
drawing each individual kidney ROI is independent. The results indicate that 
manual kidney ROI causes more variation than semi-automatic one, both between 
and within observers. The variation between observers of semi-automatic kidney 
ROI was not equal. The semi-automatic method might be expected have no 
variability, but it is not fully automatic. Inconsistencies in drawing the size of the 
box around the kidney are a source of small variability. Each observer was not 
equally consistent at placing the box around kidneys at the same size and position. 
 
The disadvantage of the semi-automatic ROI technique is that it does not work 
with severely diseased kidneys, because the algorithm cannot separate kidney 
from the high background level. In these instances the manual ROI drawing has to 
be used instead. In 5 of 65 clinical dogs, due to very poor uptake, the algorithm 
did not work, and the semi-automatic kidney ROI drawing could not be used. In 
practice this is not important unless subtle improvements due to treatment are 
being measured. 
 
Background activity correction (Paper I) 
In Paper I, the perirenal kidney background ROIs at 1 or 2 pixels from the kidney 
ROI gave the best correlation coefficients using both manual ROI and semi-
automatic ROI. Placement 1 or 2 pixels out from the kidney ROI ensures that no 
renal activity is included in the background ROI. Two pixels out from manual 
kidney ROIs would ensure no kidney activity in the background if the ROIs were 
drawn too tightly around the kidney, but particularly in small dogs, these 
background ROIs may overlap the opposite kidney. If the area facing the renal 
hilus is included in the background ROIs, a large amount of radiotracer excreted 
into the renal pelvis may appear in the ROI at the late phase, overestimating the 
background activity, and thus decreasing the net kidney counts in the late phase.  
This could be a substantial source of error in hydronephosis, but can be reduced 
by drawing the kidney ROIs from the early phase of the renogram (60- 120 
seconds summed image), and only using the early part of the TAC for calculation, 
as we did. 
The manually drawn backgrounds as small areas at the cranial and caudal poles 
of the kidneys (Krawiec et al., 1986; Twardock et al., 1996; Barthez et al., 1998; 
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Daniel et al., 1999), or only the caudal pole of the kidneys (Lora-Michiels et al., 
2001) used in previous studies in dogs are probably not as accurate as the perirenal 
background as they sample only small parts of the background (Figure 9). The 
percentage uptake using a ROI at only the caudal pole or at both poles of the 
kidney was 33% and 5% higher respectively than with perirenal ring background 
ROI. The correlation coefficients using perirenal background (r = 0.80) was higher 
than with these two background ROI methods (r=0.67 and r=0.58) (in 
preparation). These small ROIs would be subject to greater individual variation 
than the larger perirenal ROI (Figure 4). 
 
 
Figure 9. Showing different types of kidney background ROI in a dog. Note the percentage 
uptake of kidney ROIs after correction with background ROI are different. 
 
 
The effect of color tables on kidney depth measurement  
(Paper III) 
 For the first observer, the within observer variation of the depth measurement 
between threshold and continuous red-green-blue color caused variation of the 
estimated GFR up to 4 % and 6 % of the RK and LK respectively. For the second 
observer, the variation was higher, approximately 7% for both kidneys. The 
variability between the two different colors of the second observer was higher than 
that of the first observer. The different variation of observers could be explained 
by the observers selecting different points on the slope of the edge of the profile of 
counts on the line between kidney and body surface. The continuous red-green-
blue table caused more between-observer variation than the threshold table, both 
in the mean difference and 95% limits of agreement. 
 
The threshold table measured a greater kidney depth value than the continuous 
red-green-blue table, causing higher percentage uptake and higher estimated GFR. 
With continuous red-green-blue table, the measurers apparently consistently 
selected a point on the body surface at the high side of the count curve of the 
gradual transition at the edge of the continuous tone margin. The systematic 
relatively greater depth with the threshold method was adjusted for in the 
regression equation between uptake and plasma clearance GFR. 
 
To minimize the variation of GFR affecting by kidney depth measurement, a 
threshold scale which produces a consistent sharp edge should be used rather than 
a continuous color or grey scale. The choice of threshold percent should be 
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determined by testing. To ensure an accurate result, the same threshold color scale 
must be used for the examination as for the derivation of the regression equation. 
 
Errors in measuring kidney depth could also be caused when selecting the center 
of the kidney. The center of the kidney may be erroneously located in the renal 
pelvis because most of the tracer has left the renal parenchyma by the time of 
making the lateral static view (Prigent et al., 1999). The pelvis may not be in the 
same plane for measuring as the center of the kidney. Placing the dog on its back 
may reduce this effect. Another inherent disadvantage of the single lateral view for 
attenuation correction is that in some instances, the location of the center of each 
kidney is imprecise when the two are superimposed on each other. In addition, in 
dogs with very poor kidney function and high background activity, the kidneys 
sometimes cannot be located accurately. The kidney further from the camera (left 
in our studies) is less well defined due to greater attenuation. This could be 
corrected by taking a static view of the opposite side, without moving the dog. 
Determination of a geometric mean of renal activity using a dual-detector gamma 
camera obviates the need to measure kidney depth for calculating the percentage 
uptake for estimating GFR and results in improved accuracy and reduced the time 
required for acquisition compared with single-detector cameras (Delpassand et al., 
2000). However, dual-headed cameras are not universally available. 
 
Attenuation coefficient factor  
The attenuation coefficient is also considered to have a substantial effect on the 
accuracy of the attenuation correction (Prigent et al., 1999; Inoue et al., 2000). The 
linear attenuation coefficient for 99mTc in water is 0.153/cm, and this value is 
routinely used to correct for soft tissue attenuation in renography with 99mTc-
DTPA as (Gates, 1982; Krawiec et al., 1986). We followed these examples. The 
effective attenuation coefficient should be lower because of scattering photons, 
and reported values from phantom experiments have a wide range from 0.10 to 
0.14/cm (Taylor et al., 1995; Prigent et al., 1999). However, phantom experiments 
may not provide a sufficiently reliable attenuation coefficient for radionuclide 
renography. The optimal attenuation coefficient for the estimation of GFR by 
renography in humans was determined to be 0.087/cm in one study (Inoue et al., 
2000). At the present, there is no agreement on the correct 99mTc linear attenuation 
coefficient; different values in different laboratories may lead to an apparent 
change in a patient examined in different departments (Prigent et al., 1999). But 
one study suggested that the theoretical value of linear attenuation coefficient 
(0.153) is accurate when renal activity is measured using background subtraction 
as most scatter will be removed by the subtraction (Hindie et al., 1999). 
 
Time interval for measuring uptake (Paper I) 
Integral method 
In paper I, 50 of 58 individual renograms of normal beagles peaked before 180 
sec. The mean of the peak time of TAC was 131± 30 (SD) seconds following 
injection.  With the integral method, the correlation coefficients derived from 
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linear regression analysis of the GFR by 99mTc-DTPA plasma clearance and the 
percent dose uptake using different time intervals are shown in Table 1. 
 
Time intervals (sec) Manual kidney 
ROIs drawing 
Semi-automatic kidney 
ROIs drawing 
60-180 0.60 0.59 
60-120 0.77 0.77 
30-120 0.78 0.80 
30-peak 0.71 0.71 
straight line part 0.74 0.74 
 
Table 1. The average of correlation coefficients derived from linear regression analysis of 
99mTc-DTPA plasma clearance method and with the integral methods of measuring 99mTc-
DTPA uptake at different time intervals using different distance of background ROI. With 
semi-automatic kidney ROIs, the value was the average from the different percent 
thresholds of kidney ROIs. 
 
With both manual and semi-automatic kidney ROI drawing, the percentage dose 
of 99mTc-DTPA between 30–120 seconds gave the most accurate estimation of 
GFR compared to GFR by plasma clearance method. A histogram (Figure 10) 
shows the distribution of peak time of the TACs of the 58 normal kidneys  
(Paper I).  
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Figure 10. A histogram of peak time of 58 normal renograms. 
 
The vascular phase was always completed by 30 seconds and the peak time of 
TAC was 131± 30 (SD) second after injection. Within the published time interval 
of 60 –180 seconds (Krawiec et al., 1986; Twardock et al., 1996), most curves had 
started to decline particularly when  function and diuresis were good (Kunze, Bahr 
& Lees, 2006), and GFR values would have been underestimated because this time 
interval would not have been physiological valid. Therefore using the time interval 
of 30–120 seconds fulfilled in all but a few cases the physiologic requirement that 
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no activity left the kidney (Figure 10). The time to peak of excretion of 99mTc-
DTPA variability can be influenced by the degree of kidney function, hydration, 
diuresis and pelvic volume (Granerus, 2000; Kunze et al., 2006). Slight 
underestimation of GFR of dogs with good diuresis would not be clinically 
important. 
 
By its definition the integral method must have a fixed and constant time 
interval for all kidneys. The start point should be after vascular transit time. The 
last point should be selected before any significant escape of the tracer from the 
renal ROI occurs. The short time interval 30–120 seconds gives a low number of 
data points. This is however unavoidable, as a fixed time interval that suits almost 
all TACs must be used. The time interval 60–120 seconds is a even shorter curve 
with even fewer data points and thus more variability. 
 
Slope method 
With the slope uptake method, 60–180 seconds and 60–120 seconds time intervals 
had many negative values because the curve often ended lower than when it 
started at 60 seconds. Even 30–120 seconds gave a poor result because the slopes 
were highly variable. Only the variable interval of 30 seconds to peak gave 
reliable slopes but which were more sensitive to kidney and background threshold 
choices than the integral method. 
 
Method of calculation of uptake (Paper I) 
With the slope uptake method, the best correlation with known GFR by 99mTc-
DTPA plasma clearance using semi-automatic ROI and manual ROI was found at 
the time interval of 30 second to peak of TAC with correlation coefficient (r) = 
0.85 for semi-automatic ROI and r = 0.83 for manual ROI. The best correlation 
coefficient using slope uptake method was slightly higher than with the integral 
method using both kidney ROI drawing methods. With the integral method, the 
best correlation using semi-automatic ROI and manual ROI was found at the time 
interval of 30–120 seconds of TAC with r = 0.84 and 0.81 respectively. 
 
However, the slope method was less stable than the integral method, as changes 
of time intervals caused a big drop in correlation coefficient, and the offset (Y-
intercept) was also high, at 1.85 ml/min/kg. The much higher offset of the 
regression with the slope method was probably caused by the few data point of the 
kidney uptake TAC as in some dogs had a very short uptake time. It may also 
reflect a greater effect during the uptake period of declining plasma activity on the 
slope than on the total counts. To correct for this directly requires a plasma curve 
from a heart ROI, of standard size and consistent placement, in itself a source of 
error (Rehling et al., 1985; Peters, 1991; Moonen & Granerus, 1992). 
 
When using DTPA as the tracer with low renal extraction fraction of 20%, the 
correction of the intravascular component of the background is important. This 
may be achieved with the uptake index method (Rutland-Patlak plot) (Prigent et 
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al., 1999). Neither of the methods we used for calculating uptake takes into 
account the decrease in plasma concentration during the time interval since it was 
not planned at that time. In humans, the mean slope method is not recommended 
because it is not validated in the literature (Prigent et al., 1999). According to this 
European Consensus report, the two recommended methods, which probably 
perform similarly well for GFR meansurement, are the integral method and the 
uptake index method (Rutland-Patlak plot) (Prigent et al., 1999). Because of its 
greater stability with different ROIs, we recommend the integral method over the 
slope method. The uptake index method was not tested. 
 
Regression equation for GFR calculation (Paper I) 
The regression equation by the integral method used to predict the GFR was 
slightly different between manual and semi-automatic kidney ROIs drawing. 
  
For semi-automatic ROI drawing:  
 
predicted GFR = 0.44 x percentage uptake of injected radioactivity+0.87 
 
For manual ROI drawing:  
 
predicted GFR = 0.45 x percentage uptake of injected radioactivity+0.90 
 
Our regression equation was different from the two previous published 
equations for dogs (Krawiec et al., 1986; Barthez et al., 1998). Many differences 
between laboratories can cause the regression equations to be different: labeling 
efficiency, camera sensitivity, methods of ROI drawing and attenuation 
determination, and the range of GFRs used for the regression equation. The 
sample population would not affect the regression equation, as long as it includes 
a wide range of GFR down to severely decreased function. A deficiency of our 
regression equation is that it did not include low GFRs. This inclusion may have 
changed the slope and intercept of regression. 
 
The Bland-Altman plot, comparing GFR estimated by scintigraphy using the best 
factors for the integral method (Paper I) with GFR by plasma clearance in the 
normal dogs (Figure 11), gave 95% limits of agreement of ± 0.67 ml/min/kg. This 
means that any measurement by this scintigraphic method has 95% likelihood of 
truly being with these limits, assuming the conditions are the same as in Paper I. In 
renal failure the estimate is not likely to be as accurate. 
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Figure 10 Bland-Altman plot of the GFR comparing between GFR by plasma clearance 
method and scintigraphy 
 
The overall repeatability variation of the integral method 
(Papers I and III) 
There was no significant effect on the repeatability of measurement in normal 
dogs by the same observer in Paper II. The CV% of the global estimated GFR of 
this observer for the repeated measurement was 1.74% ranging from 0.37 to 4.13 
± 0.9% (SD).The within-observer repeatability coefficient was 0.21 ml/min/kg, 
which means that the variation of the global estimated GFR was up to 5%. 
 
In paper III, the overall repeatability variation combined the effects of different 
color tables for measuring kidney depth and the effects of kidney ROI drawing 
technique. The choice of color scale for measuring kidney depth and ROI drawing 
affected the overall variability. The repeatability using the semi-automatic ROI 
drawing was higher than with the manual one with both color scales, but was not 
equal between observers. The threshold table gave slightly less intra-observer 
variation. 
 
The variations found in Paper II, using semi-automatic ROI and threshold table 
were less than in Paper III. The kidneys of Paper III were of clinical patients with 
a wide range of kidney function, whereas in the Paper II only healthy kidneys 
were studied. Moreover, in Paper II the variability of measurement was evaluated 
for the global GFR, not for the individual kidney. The variability of each kidney 
may be additive or subtractive in their effects on global GFR. The combination of 
variation due to kidney depth measurement and kidney ROI drawing in Paper III 
could cause a variation of estimated GFR up to 10 % compared to 5% in Paper II. 
When comparing the overall reproducibility due to color tables and ROIs on GFR 
with their effects on individual kidneys, the results were less than the additive 
effects of both factors, indicating that overall the effects were partially additive. 
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However, this result does not eliminate the possibility in the individual patient that 
the variability of the kidneys is fully additive. 
 
In some circumstances one individual factor may be eliminated to reduce 
variability. For example, when monitoring how an intervention affects GFR under 
anesthesia, the dogs do not move, and the kidney depth is constant, therefore only 
kidney ROI drawing is a cause of variability. In clinical patients in which only one 
kidney is functioning, the variability arises from only that kidney. 
 
The physiological variability of GFR (Paper II) 
The variation of GFR on the individual dogs and on the different days was 
measured by one person (NK) by scintigraphy in the normal dogs (Paper II). There 
was a significant difference of GFR between dogs and in the same dog on 
different days (day to day variation). The lowest total GFR value of these healthy 
dogs was 2.66 ml/min/kg and the highest was 5.67 ml/min/kg. The mean total 
GFR was 3.97 ± 0.72 (SD) ml/min/kg, slightly different and higher than the value 
in normal dogs by plasma clearance method (Paper I). The variation in 
characteristics of dogs and the physiologic variability may affect the normal values 
obtained by different laboratories by different methods (Heiene & Moe, 1998). 
The 95 % confidence interval for the difference of GFR measurement on the same 
dog but on different days was ± 1.6 ml/min/kg. The mean percent coefficient of 
variation (CV %) of all measurements of all dogs on different days of GFR 
(difference between the three day to day values) was 8.45%, close to the value in 
humans using a gamma camera and uptake index method, in which the normal day 
to day variation in GFR was 8.8% (Rehling et al., 1986). 
 
The day to day differences in GFR within and between dogs in our study may be 
influenced by several nonrenal factors such as protein intake, hydration status, 
sodium balance, and gender. In humans, GFR and renal plasma flow increase 20-
30% within one or two hours after a person has eaten a high protein meal (Guyton 
& Hall, 2000). In our study the dogs were fed using the same food for the entire 
study period but the amounts eaten were not controlled as we wished to replicate 
the conditions of practical use as mush as possible. 
 
The state of hydration has been shown to affect the GFR value. Because the 
state of hydration of a dog cannot be precisely determined by inspection, the effect 
of dehydration should be minimized by administration of fluids. Usually, GFR 
values above 3 ml/min/kg have been considered as normal (Daniel et al., 1999). In 
paper II, the water intake was not controlled, but was available ad lib. In some 
examinations, the GFRs were below 3 ml/min/kg indicating the dogs may have 
been slightly dehydrated on these occasions. However, no dog in paper II had a 
GFR value below 3 ml/min/kg at more than once of the three measurements. False 
interpretations of reduced kidney function in dogs because the GFR measurement 
was lower than normal range has been reported (Kampa & Lord, 2004).  
The regression of body weight on GFR was a horizontal line, showing no 
systematic effect of bodyweight on the GFR (Figure 11). Among our dogs, the 
 42
body composition was quite variable, some dogs were fat and others rather thin, 
with a range of body weight from 10 to 21 kg for the same breed. Fat has a low 
metabolic rate and low fluid content, contributing little to GFR and thus the 
assumption that GFR is directly proportional to body weight is untrue and almost 
certainly contributes to the variability. 
 
The regression of body weight and GFR
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Figure 10.  The correlation of body weight and GFR in 18 normal dogs, the GFR of each 
dog was averaged from the three measurements. 
 
Normalization of GFR to plasma volume (GFR/PV 
measurement) (Paper IV) 
The effect of LV ROI sizes 
The results were similar both normal and clinical (unknown condition) dogs. The 
difference was only in the value, as the clinical material included many kidneys 
with decreased function, and in many dogs, total GFR was low and 
consequencely, background activity was high. There was no significant difference 
in the results using the different types of the LV ROI in normal and clinical dogs, 
confirming the hypothesis that the theoretical irrelevance of size was correct. 
Although the sizes of LV ROI did not significant affect the GFR/PV, we 
recommend using the manual LV ROI. In practice the fixed automatic size of LV 
ROI may not be suitable for different sizes of dogs. Using a small LV ROI on a 
large heart may increase statistical errors or the LV ROI may not be not centered 
on LV consistently. Although a small heart ROI includes less EV background 
activity from the lung than a large one, the count rate is lower, thus decreasing the 
statistical confidence (Moonen et al., 1994a). Using a large LV ROI in a small dog 
may include much lung and background activity in the chest wall relative to LV 
activity.  
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The effect of EV activity 
Subtraction of EV background activity over the LV caused a significant difference 
in GFR/PV values in both normal and clinical groups. The assumption that a ROI 
over the heart following injection of 99mTc-DTPA, even a small one confined to 
the LV, records only the activity which originates from blood (Peters et al 1994), 
is not exactly true (Bell & Peters, 1991). The contribution of EV activity to the 
total activity recorded over the heart was calculated to be 11% at 1.5 minutes after 
DTPA injection, rising to 35.1% at 15 minutes (Bell & Peters, 1991). In our study, 
the average of the total GFR/PV of normal dogs and clinical dogs with EV 
subtraction were approximately 17% higher than without EV subtraction using the 
time interval for the plasma activity curve between 1–4 minutes, which 
corresponds to an interpolation of the above results in humans over the same time 
period. 
 
It is also found that the effect of EV activity was greater with the shorter time 
intervals (30 – 120s) than the longer time intervals (60 –240s) for LV plot as the 
GFR/PV value measured with EV, 25% higher than without EV subtraction. EV 
subtraction increased both the mean difference and the 95% limits of agreement of 
the small compared to the large LV ROI, and of the short (30 –120s) and long (60 
–240s) time intervals for the LV (t) plot. These effect of EV subtraction can be 
explained. 
 
The measured plasma activity of 99mTc-DTPA in the intravascular space 
obtained by LV ROI is decreased using EV subtraction, and this effect is greater 
later in the acquisition as EV activity rises.  The subtraction of the EV signal 
causes the slope of the plasma activity curve to be steeper than without subtraction 
as during the time interval some activity moves from intravascular space to EV 
space, and the value of LV (0) and slope α are increased increasing GFR/PV. After 
EV subtraction, the LV curves were often very noisy compared to those without 
EV subtraction, because the total counts became very low. This was due to the EV 
ROI representing not only EV activity alone but also including the activity in the 
lung blood pool, which means blood activity is being subtracted from blood 
activity. In our study, the EV ROI was placed over the right lung to try to avoid 
the large vessels such as aorta. But sometime it was difficult to avoid these 
vessels. Thus the EV ROI activity, which actually has a large inadvertent 
intravascular component, becomes a large proportion of the LV ROI activity and 
the net counts are low and the curve noisy. 
 
The effect of different time intervals for LV curve 
Different time intervals for the LV TAC significantly affected the results in 
normal and clinical dogs. The mean of the total GFR/PV of clinical dogs with time 
intervals of plasma activity curve at 30 –120 seconds time interval was 14% 
higher than using the time interval between 1-4 minutes measured without EV 
subtraction. In normal dogs, the difference in GFR/PV value was greater at 24%. 
The effect of time interval on LV plot is greater when subtracting EV activity. The 
lower difference in the clinical group is because the shorter time intervals of the 
 44
diseased kidneys were often long (3–4 minutes) whereas the peak time of TACs in 
normal kidney were usually 2-3 minutes. LV semilogarithmic plots with long time 
interval have more EV activity, less slope and intercept, (LV(0)),  and lower 
GFR/PV value than that with a short time interval. 
 
In principle, it is more physiologically correct to use the time interval from only 
the kidney uptake phase as there is less EV activity earlier than later. But in 
practice, some kidneys have a very short time of kidney uptake phase, no more 
than 30 – 90 seconds after injection, therefore only a few data points of LV curve 
are obtained and used, which makes the slope and intercept susceptible to 
statistical error, especially when the curve is noisy after subtracting EV 
background activity. Although the time intervals between 1 and 4 minutes may not 
physiological correct in that EV activity becomes an increasing fraction of the 
activity, to minimize the variation due to few data points, we recommend using a 
longer time such as 1 to 4 minutes. 
 
Since there is no reference value as the gold standard, the normal value ranges 
of GFR/PV depend on which method or parameters are chosen.  The GFR/PV 
value in normal dogs obtained by manual heart ROI and no EV subtraction and 
time interval for LV plot between 1 and 4 minutes was the following: the mean 
GFR/PV ± SD of the left kidney was 25.3 ±8.5 ml/min/L, ranging 14.4–51.0 
ml/min/L. The right kidney was 23.3 ± 6.9 ml/min/L ranging 14.8 –42.6 ml/min/L. 
The global GFR/PV was 48.5 ± 14.4 ml/min/L ranging 33.5– 99.6 ml/min/L. 
These values are slightly higher than those obtained in humans by Peter et al. 
(1994a). 
 
It is to be realized that the normalized GFR is not a measure of kidney function 
alone (as the absolute GFR is) but instead is a measure of kidney function in 
relation to the environment, in this study, PV. From our data, it cannot say that 
normalizing GFR to PV is more accurate than absolute GFR related to BW, 
because there is no objective method of comparing these two methods. Change in 
body fluid volume and PV influence absolute GFR and GFR related to fixed body 
parameters such as BW. GFR normalized to PV adjusts for these variations which 
do not affect intrinsic kidney function, and thus is a physiologic unit. One possible 
factor limiting measurement of GFR/PV is that the heart in large dogs may not 
always be included in the field of view of the camera; therefore the LV ROI 
cannot be obtained. In these cases, drawing ROI over aorta may be used instead 
and this needs to be tested. 
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Conclusions 
The following conclusions can be drawn from the studies: 
 
1. Determination of sources of variability and improvement 
 
i. The semi-automatic kidney ROI drawing was slightly better than manual 
kidney ROI drawing in term of accuracy and variation within and between 
observers. A semi-automatic kidney ROI drawing should be used whenever 
possible.  20% threshold percent of the maximum pixel activity is 
recommended for semi-automatic kidney ROI drawing. 
 
ii. The most suitable perirenal background ROI is one pixel out from the 
kidney ROI, and one pixel wide with a 64x64 pixel matrix. 
 
iii. The choice of color scales for measuring kidney depth affects the calculated 
attenuation and causes variations in the estimated GFR. The kidney depth 
measurement using continuous red-green-blue color scale causes greater 
variation than a threshold scale. A threshold color scale is recommended. 
 
iv. The time interval between 30 – 120 seconds is recommended as being the 
most accurate and physiological for calculating the percent dose uptake by 
the integral method. 
 
v. The integral method was less affected than the slope method by variations 
in kidney and background ROIs, and is recommended. 
 
vi. The repeatability of the method is high and acceptable in the clinic. 
However, the variability of each observer is not equal. It is recommended 
that in sequential examinations the same person should make all the 
measurements. 
 
2. Physiological variability of GFR: the normal range of GFR is wide, which 
reflects changes in response to physiological needs. The variability of GFR 
between dogs is higher than day to day variability within dogs and the 
measurement variability indicating that these physiological changes are 
different from dog to dog. They may be affected by the method of 
normalization to BW. 
 
3. Normalizing GFR to plasma volume:  
 
i. Different LV ROI sizes had no significant effect on the results, but as 
manual LV ROI is more flexible in adapting to different sized dogs, it is 
recommended. 
  
ii. There was significant effect of EV activity subtraction on the results and 
the variation was greater than without EV subtraction. Therefore, it is not 
recommended. 
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iii. Different time interval of LV plot had significant effect on the values. 
Shorter time intervals, had greater variability, thus LV plot time intervals of 
1–3 or 4 minutes are recommended. 
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Future perspectives 
It would be of interest to continue study further: 
 
1. Improvement of the methods 
 
• It would be of interest to include dogs with impaired kidney function with 
known GFR by plasma clearance method in the study and see if there is 
better correlation coefficient.  
 
• A new method of semi-automatic kidney ROI drawing using smoothing 
technique and threashold has been developed in our department. This 
should also be tested if there is improving of the accuracy and reducing the 
variability either of method or observer. 
 
• The dynamic study acquisition at higher resolution, 128 x 128 matrix sizes 
should be used and tested to obtain the new regression equation. 
 
2. Comparing variation of GFR related to BW and GFR/PV 
 
• It would be of interest to investigate the accuracy and sensitivity of the 
gamma camera method (GFR and GFR/PV measurement), which method 
is the least sensitive to variations in kidney & background ROI drawing 
and kidney depth measurement. 
 
• It would be of interest to test the effect of fluid on GFR/BW (kg) compared 
to GFR/PV measurement. Increased plasma volume should not affect 
GFR/PV. 
 
3. Other interesting perspectives would be to for evaluating kidney function 
compared to the finding from ultrasound and pathology as kidney biopsy in 
the clinic.  
 
4. The GFR/PV method may be adaptable to use in horse. Because of the large 
size of the animal, the heart would not be in the field of view. A plasma input 
ROI over the aorta would have to be used.  
 
5. The comparison of renal scintigraphy between 99mTc-DTPA and 99mTc-MAG3 
(mercaptoacetyltriglycine) would also be tested. MAG3 is tracer with much 
greater renal extraction than DTPA. 
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